Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,086 INR | +0.16% | +3.23% | +52.23% |
Sales 2024 * | 8.45B 101M | Sales 2025 * | 10.78B 129M | Capitalization | 55.18B 661M |
---|---|---|---|---|---|
Net income 2024 * | 908M 10.88M | Net income 2025 * | 1.42B 17.04M | EV / Sales 2024 * | 6.41 x |
Net cash position 2024 * | 1.06B 12.66M | Net cash position 2025 * | 1.2B 14.35M | EV / Sales 2025 * | 5.01 x |
P/E ratio 2024 * |
60.3
x | P/E ratio 2025 * |
38.9
x | Employees | 838 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.03% |
Latest transcript on Orchid Pharma Limited
1 day | +0.16% | ||
1 week | +3.23% | ||
Current month | +3.95% | ||
1 month | +3.95% | ||
3 months | +51.70% | ||
6 months | +133.27% | ||
Current year | +52.23% |
Managers | Title | Age | Since |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 31/20/31 |
Director of Finance/CFO | - | 29/20/29 | |
Kapil Dayya
CMP | Compliance Officer | - | 16/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 31/20/31 | |
Mridul Dhanuka
BRD | Director/Board Member | 42 | 31/20/31 |
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 31/20/31 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 1,086 | +0.16% | 7,930 |
26/24/26 | 1,085 | -0.75% | 7,964 |
25/24/25 | 1,093 | +2.85% | 3,421 |
24/24/24 | 1,063 | +0.37% | 8,112 |
23/24/23 | 1,059 | +0.60% | 4,229 |
Delayed Quote Bombay S.E., April 29, 2024 at 03:30 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- ORCHPHARMA Stock
- ORCHPHARMA Stock